Supreme Court to Decide Fate of Thousands of Roundup Cancer Lawsuits
High court will hear arguments in landmark case that could end litigation claiming Bayer's herbicide causes cancer.
The Supreme Court announced it will hear arguments in a high-stakes case that could determine the fate of thousands of lawsuits against Bayer claiming the company's Roundup weedkiller causes cancer. The decision represents a critical moment for both the pharmaceutical giant and cancer victims who allege the glyphosate-based herbicide led to their diagnoses of non-Hodgkin's lymphoma.
Bayer, which acquired Roundup manufacturer Monsanto in 2018, faces an estimated 40,000 pending lawsuits related to the herbicide. The company has already paid billions in settlements and jury verdicts, but continues to maintain that Roundup is safe when used as directed. A victory for Bayer at the Supreme Court level could effectively end the remaining litigation and provide the company with long-sought legal closure on one of its most expensive ongoing liabilities.
The case centers on whether federal regulation of pesticides preempts state-level tort claims. Bayer argues that because the Environmental Protection Agency has approved glyphosate for use and does not require cancer warnings on Roundup labels, individual states cannot allow juries to find the company liable for failing to warn consumers about alleged cancer risks. The company contends that allowing such lawsuits undermines federal regulatory authority and creates a patchwork of conflicting state requirements.
Plaintiffs' attorneys counter that federal approval does not shield manufacturers from liability when they fail to adequately warn consumers about known risks. They point to internal Monsanto documents revealed during previous trials that allegedly show the company was aware of potential cancer risks but downplayed them in public communications. These attorneys argue that state tort law provides crucial protections for consumers that complement rather than conflict with federal oversight.
The Supreme Court's ruling could have implications extending far beyond Roundup, potentially affecting how courts handle product liability cases involving federally regulated substances ranging from pharmaceuticals to chemicals. Legal experts note that the decision may influence the balance between federal regulatory authority and state-level consumer protections, with significant consequences for both industry and public health advocates.
